0001650664-24-000060.txt : 20240603 0001650664-24-000060.hdr.sgml : 20240603 20240603163027 ACCESSION NUMBER: 0001650664-24-000060 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240530 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reeve Emma CENTRAL INDEX KEY: 0001680329 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 241014103 MAIL ADDRESS: STREET 1: C/O PAREXEL INTERNATIONAL CORPORATION STREET 2: 195 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 wk-form4_1717446617.xml FORM 4 X0508 4 2024-05-30 0 0001650664 Editas Medicine, Inc. EDIT 0001680329 Reeve Emma C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 1 0 0 0 0 Stock Option (right to buy) 5.17 2024-05-30 4 A 0 25000 0 A 2034-05-29 Common Stock 25000 25000 D This option was granted on May 30, 2024 and is scheduled to vest in full on May 30, 2025 /s/ Emma Reeve 2024-06-03